Clinical Trials
Braintumor Website

There are 30 trials:
Facility: National Institutes of Health Clinical Center, 9000 Rockville Pike
NCT Trial Name# of Centers

NCT01222754

  Lenalidomide and Radiation Therapy in High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas
6

NCT00302159

  Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors
3

NCT00598351

  Natural History Study of Patients With Neurofibromatosis Type 2
1

NCT00880061

  An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-grade Glioma
1

NCT00995007

  A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas
1

NCT01117168

  Enrollment on the Childhood Cancer Research Network (CCRN) of the Children s Oncology Group
1

NCT01222728

  Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients
1

NCT00001595

  An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
1

NCT00001686

  Evaluation, Treatment, and Natural History of Children With Cancer
1

NCT00009035

  Natural History of Patients With Brain and Spinal Cord Tumors
1

NCT00054756

  Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities
1

NCT00060541

  Evaluation and Treatment of Neurosurgical Disorders
1

NCT00267865

  Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma
1

NCT01222780

  To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer
1

NCT01386450

  AZD6244 in Children With Low-Grade Gliomas
1

NCT01434602

  Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas
1

NCT01445288

  Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors
1

NCT01445483

  Neuropsychological Changes in Patients Receiving Radiation Therapy for Brain Metastases
1

NCT01454596

  CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII
1

NCT01679743

  GRN1005 for Brain Metastases From Breast or Lung Cancer
1

NCT01875601

  NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors
1

NCT02069080

  Imaging CXCR4 Expression in Subjects With Cancer Using 64 Cu-Plerixafor
1

NCT02108002

  Effect of Vorinostat on Nervous System Hemangioblastomas in Von Hippel-Lindau Disease (Missense Mutation Only)
1

NCT02153957

  Trial Evaluating an Enhanced Physical Activity Intervention to Improve Cognitive Late Effects in Children Treated With Cranial Radiation for Brain Tumors
1

NCT02179515

  Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM)
1

NCT02203526

  Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Dose-Adjusted-Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (DA-TEDDI-R) in Primary CNS Lymphoma
1

NCT02390752

  Phase I/II Trial of PLX3397 in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN)
1

NCT02644512

  Phase II Trial of the MEK1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas
1

NCT02709226

  Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
1

NCT01174121

  Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
1



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites